Drug Type Small molecule drug |
Synonyms A1752 |
Target |
Mechanism HIV-1 protease inhibitors(HIV protease inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H12ClNO4S2 |
InChIKeyYZLFZFALAZYTCI-ZROIWOOFSA-N |
CAS Registry2055732-24-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | KR | - |